Pharmacogenomics' Next Step: Public Workshop In April
This article was originally published in The Pink Sheet Daily
Executive Summary
After releasing a final guidance for industry data submissions, FDA continues to seek input on additional pharmacogenomic guidances. The agency will release a concept paper on co-development of drugs and diagnostics for the April 11-13 workshop.
You may also be interested in...
FDA/EMEA To Hold Joint Pharmacogenomic Meetings
FDA and the European Medicines Agency will offer voluntary genomic data submission sponsors the option of joint FDA/EMEA briefing meetings, the agencies said May 31
FDA/EMEA To Hold Joint Pharmacogenomic Meetings
FDA and the European Medicines Agency will offer voluntary genomic data submission sponsors the option of joint FDA/EMEA briefing meetings, the agencies said May 31
FDA's Woodcock Keynotes Meeting On Imaging In Drug Development
The agency's Critical Path initiative targets identification of surrogate endpoints using imaging technologies. DIA and BIO are cosponsoring the May 5-6 conference with FDA.